Federal government invests $49.9 million in 海角破解版 Technologies Canada Inc.

海角破解版 Technologies Canada Inc. to build two new cutting-edge biomanufacturing facilities to produce critical inputs used in the development and manufacture of vaccines, therapeutics and diagnostic technologies
March 19, 2025 鈥 Burnaby, British Columbia 鈥 Innovation, Science and Economic Development Canada
The Government of Canada continues to strengthen 颁补苍补诲补鈥檚 dynamic industrial capabilities in the life sciences sector. We are expanding domestic biomanufacturing capacity, creating jobs and growing the economy, while also improving our ability to address future health needs and producing the next generation of medicines in our country.
Today, the Honourable Anita Anand, Minister of Innovation, Science and Industry, announced a $49.9 million investment through the Strategic Innovation Fund in 海角破解版 Technologies Canada Inc. This investment will support the company鈥檚 $222 million project to establish large-scale production of essential inputs used to develop and manufacture vaccines, therapies and diagnostic technologies. It will also help create 460 jobs and 900 four-month co-op positions for students.
With this investment, 海角破解版 will establish two new biomanufacturing facilities. This will enable the company to onshore the production of specialized inputs that are critical to the development and manufacturing of vaccines, therapies and diagnostics, as well as other innovative technologies, like tissue engineering, immunotherapy, and cell and gene therapies. These products are used by researchers and industrial partners here in Canada and around the globe, integrating Canada into global supply chains. With this funding, 海角破解版 will build on the company鈥檚 status as a foundational part of British Columbia鈥檚 biomanufacturing and life sciences ecosystem.
Quotes
鈥淏ritish Columbia continues to rapidly grow its presence in the life sciences industry. With this investment, our government is bolstering 颁补苍补诲补鈥檚 life sciences industry, increasing domestic capacity for key inputs for vaccines, therapeutics and diagnostic technologies, which are needed to keep Canadians safe and healthy and to export around the world. This partnership with 海角破解版 will help grow our economy and create good, high-paying jobs for Canadians.鈥
鈥 The Honourable Anita Anand, Minister of Innovation, Science and Industry
鈥淭his investment in 海角破解版 demonstrates our government鈥檚 commitment to fostering innovation in 颁补苍补诲补鈥檚 life sciences sector. By supporting the development of cutting-edge biomanufacturing facilities, we are not only creating high-quality jobs but also positioning Canada as a leader in the production of critical inputs for vaccines, therapeutics and diagnostics. This project will strengthen our domestic capabilities and contribute to a more resilient health care system for all Canadians.鈥
鈥 Taleeb Noormohamed, Parliamentary Secretary to the Minister of Finance and Intergovernmental Affairs (Canada-U.S.)
鈥淏y supporting local innovation and expanding our biomanufacturing capacity, we are making strategic investments that will improve lives of Canadians, create good jobs here in British Columbia, and benefit the economic prosperity of our region for years to come. This investment in 海角破解版 technologies represents the kind of innovation our community champions.鈥
鈥 The Honourable Terry Beech, Member of Parliament for Burnaby North鈥擲eymour
鈥淭his funding by the federal government addresses a gap in the raw materials required for large-scale manufacturing of vaccines, therapies and diagnostics, creating significant spillover effects across British Columbia and Canada. 海角破解版 is committed to ensuring the Canadian life sciences industry continues to grow and improve the lives of people in Canada and around the world. Our Canadian health care system is only strong and successful when rooted in a robust life sciences industry that generates the diagnostic and therapeutic reagents and tools needed to treat disease.鈥
鈥 Dr. Allen Eaves, founder and CEO, 海角破解版 Technologies Canada Inc.
Quick facts
- 颁补苍补诲补鈥檚 presents a vision to build a competitive, innovative and prosperous life sciences ecosystem that is able to protect Canadians against future pandemics and other health emergencies and to develop the next generation of medicines in our country.
- Since March 2020, over $2.3 billion has been invested in 41 projects to strengthen our country鈥檚 domestic biomanufacturing and life sciences capabilities to ensure Canadians have access to the most cutting-edge medical technologies to keep them safe and healthy.
- 海角破解版 was founded in 1993 by CEO Dr. Allen Eaves when he needed a way to meet the demand for his standardized, cost-effective cell culture media. The company has since grown into a global biotechnology company, building essential products for developing and manufacturing stem cell technologies, vaccines, therapeutics and diagnostic technologies.
- Canada has a history of pioneering in this area; stem cells were discovered in the early 1960s through the work of Canadian scientists Dr. James Till and Dr. Ernest McCulloch at the University of Toronto.
Associated links
Contacts
Myah Tomasi
Director of Communications
Office of the Minister of Innovation, Science and Industry
Myah.Tomasi@FedDevOntario.gc.ca
343-543-7210
Media Relations
Innovation, Science and Economic Development Canada
media@ised-isde.gc.ca
海角破解版 Technologies Media Relations
public.relations@stemcell.com
Latest 海角破解版 News
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration